BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV)
| 9.67 Delayed Data As of Jan 16 |  -0.67 / -6.48%Today’s Change | 4.65 Today|||52-Week Range 13.50 | +4.09% Year-to-Date |
Latest BVXV News | Press Releases
No recent news for BiondVax Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 10.34 |
| Today’s open | 10.59 |
| Day’s range | 9.67 - 10.64 |
| Volume | 43,657 |
| Average volume (3 months) | 21,490 |
| Market cap | $57.7M |
Data as of 3:59pm ET, 01/16/2020
Growth & Valuation
| Earnings growth (last year) | -95.97% |
| Earnings growth (this year) | +33.33% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ISRIsoRay Inc | +0.04 | +4.70% |
| ---- | ||
| EVOKEvoke Pharma Inc | 0.00 | 0.00% |
| MTPMidatech Pharma PLC | +0.02 | +1.79% |
Data as of 8:00pm ET, 01/16/2020
Financials
| Next reporting date | April 23, 2020 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$24.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Jerusalem, Jerusalem |
Forecasts
